NO20091561L - Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider - Google Patents

Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider

Info

Publication number
NO20091561L
NO20091561L NO20091561A NO20091561A NO20091561L NO 20091561 L NO20091561 L NO 20091561L NO 20091561 A NO20091561 A NO 20091561A NO 20091561 A NO20091561 A NO 20091561A NO 20091561 L NO20091561 L NO 20091561L
Authority
NO
Norway
Prior art keywords
carbonate
preparation
naltrextron
halides
alkyl
Prior art date
Application number
NO20091561A
Other languages
English (en)
Norwegian (no)
Inventor
Alain Dlubala
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20091561L publication Critical patent/NO20091561L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20091561A 2006-09-21 2009-04-20 Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider NO20091561L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone
PCT/FR2007/001516 WO2008034973A1 (fr) 2006-09-21 2007-09-19 Procede de preparation d'halogenures de n-alkyl naltrexone

Publications (1)

Publication Number Publication Date
NO20091561L true NO20091561L (no) 2009-06-16

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091561A NO20091561L (no) 2006-09-21 2009-04-20 Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider

Country Status (35)

Country Link
US (2) US7645880B2 (ar)
EP (1) EP2069362B1 (ar)
JP (1) JP5214615B2 (ar)
KR (1) KR101434693B1 (ar)
CN (2) CN101516892B (ar)
AR (1) AR062918A1 (ar)
AU (1) AU2007298855B2 (ar)
BR (1) BRPI0718440A2 (ar)
CA (1) CA2663509C (ar)
CL (1) CL2007002711A1 (ar)
CO (1) CO6170362A2 (ar)
CR (1) CR10660A (ar)
DO (1) DOP2011000307A (ar)
EA (1) EA015426B1 (ar)
ES (1) ES2531093T3 (ar)
FR (1) FR2906252B1 (ar)
GT (1) GT200900060A (ar)
HN (1) HN2009000503A (ar)
IL (1) IL197402A (ar)
JO (1) JO3023B1 (ar)
MA (1) MA30793B1 (ar)
ME (1) MEP10509A (ar)
MX (1) MX2009003084A (ar)
MY (1) MY148094A (ar)
NI (1) NI200900035A (ar)
NO (1) NO20091561L (ar)
NZ (1) NZ575417A (ar)
PE (1) PE20080867A1 (ar)
SV (1) SV2009003192A (ar)
TN (1) TN2009000080A1 (ar)
TW (1) TWI465451B (ar)
UA (1) UA96957C2 (ar)
UY (1) UY30599A1 (ar)
WO (1) WO2008034973A1 (ar)
ZA (1) ZA200901846B (ar)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
US8383649B2 (en) * 2007-07-11 2013-02-26 Mallinckrodt Llc Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
CA2738246C (en) * 2008-09-30 2017-09-05 Mallinckrodt Inc. Processes for the alkylation of secondary amine groups of morphinan derivatives
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
EP2398806A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-morphinanium n-oxides and processes for their production
US8563724B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010121369A1 (en) 2009-04-24 2010-10-28 Brock University Processes for the preparation of morphinane and morphinone compounds
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
SMT201700177T1 (it) * 2010-11-05 2017-05-08 H Lundbeck As Procedimento per la fabbricazione di naltrexone
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
MX2014002630A (es) 2011-09-08 2014-04-14 Mallinckrodt Llc Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
AR090916A1 (es) 2012-05-03 2014-12-17 Lundbeck & Co As H Metodo para la fabricacion de naltrexona
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617B (zh) * 2020-07-10 2025-06-06 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
WO2022076470A1 (en) 2020-10-06 2022-04-14 Sorrento Therapeutics, Inc. Oral delayed burst formulation of low-dose naltrexone or naloxone used for|treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
EP1562953B1 (en) * 2002-11-08 2009-09-30 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
HN2009000503A (es) 2011-03-02
CN101516892A (zh) 2009-08-26
MA30793B1 (fr) 2009-10-01
AR062918A1 (es) 2008-12-17
AU2007298855B2 (en) 2012-09-13
GT200900060A (es) 2011-01-04
AU2007298855A1 (en) 2008-03-27
JP2010504308A (ja) 2010-02-12
TN2009000080A1 (en) 2010-08-19
KR101434693B1 (ko) 2014-08-27
CR10660A (es) 2009-06-24
HK1135389A1 (en) 2010-06-04
KR20090057031A (ko) 2009-06-03
MY148094A (en) 2013-02-28
FR2906252A1 (fr) 2008-03-28
US8288547B2 (en) 2012-10-16
US7645880B2 (en) 2010-01-12
EA015426B1 (ru) 2011-08-30
CA2663509A1 (fr) 2008-03-27
ES2531093T3 (es) 2015-03-10
ME00613B (me) 2011-12-20
US20100145051A1 (en) 2010-06-10
CO6170362A2 (es) 2010-06-18
TW200821314A (en) 2008-05-16
NZ575417A (en) 2011-09-30
CN102225939A (zh) 2011-10-26
MX2009003084A (es) 2009-04-02
WO2008034973A1 (fr) 2008-03-27
TWI465451B (zh) 2014-12-21
IL197402A0 (en) 2009-12-24
EP2069362B1 (fr) 2014-07-09
ZA200901846B (en) 2010-07-28
UA96957C2 (ru) 2011-12-26
SV2009003192A (es) 2009-10-27
EP2069362A1 (fr) 2009-06-17
IL197402A (en) 2012-12-31
FR2906252B1 (fr) 2008-11-28
JO3023B1 (ar) 2016-09-05
EA200970307A1 (ru) 2009-12-30
DOP2011000307A (es) 2011-10-31
UY30599A1 (es) 2008-05-02
NI200900035A (es) 2010-01-26
CN101516892B (zh) 2012-06-20
BRPI0718440A2 (pt) 2013-11-19
MEP10509A (en) 2011-12-20
CA2663509C (fr) 2014-03-18
PE20080867A1 (es) 2008-08-22
US20080214817A1 (en) 2008-09-04
CL2007002711A1 (es) 2008-04-18
JP5214615B2 (ja) 2013-06-19

Similar Documents

Publication Publication Date Title
NO20091561L (no) Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider
NO330968B1 (no) Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
UA87389C2 (ru) Способ получения тризамещенных солей метилглицин-n,n-диуксусной кислоты и катионов щелочных металлов
MY149509A (en) Stabilized composition for producing chlorine dioxide
WO2009034932A1 (ja) アルカリ型非イオン性界面活性剤組成物
IL183700A0 (en) Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
BR0215555A (pt) Preparação de reagentes de bromação não perigosos
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
CA2547743A1 (en) Improved method for bisulfite treatment
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
HRP20180454T1 (hr) Postupak za proizvodnju 3-okso-pregn-4-en-21,17-karbolaktona pomoću bezmetalne oksidacije 17-(3-hidroksipropil)-3,17-dihidroksiandrostana
NO20076358L (no) Fremgangsmate for syntese av sulfonylhalider og sulfonamider fra sulfonsyresalter
WO2008001392A3 (en) An improved process for the preparation of pantoprazole and its pharmaceutically acceptable salts
JP2008043836A5 (ar)
NO20064884L (no) Kjemisk fremgangsmate og ny krystallinsk form
NO20060258L (no) Nematicidale tiazolin-inneholdende fluorobutener
PL1891191T3 (pl) Granulaty bentonitowe ulegające szybkiemu rozkładowi
NO20044708L (no) Fremgangsmate for fremstilling av halogenidsaltopplosning
TH135001A (th) กรรมวิธีสำหรับการเตรียม n-แอลคิลแนลเทรกโซนเฮไลด์
FR2844525B1 (fr) Procede de preparation d'une composition polycarboxylique comprenant une etape d'oxydation electrochimique d'une composition monosaccharidique
ZA200805255B (en) Ethanolic and/or aqueous composition of an ammoniacal solution of alkaline metal salts of azide, mainly sodium & potassium
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
ATE340821T1 (de) Carboxymethylcellulose mit verbesserter löslichkeit im wasser
BRMU8403319U (pt) fabricação de hipoclorito de cálcio a partir de óxido de cálcio sem purificação
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application